The Collaborative Research Centre TRR332 is a DFG-funded consortium dedicated to develop an improved understanding of neutrophil biology. Our studies will reveal mechanisms of how the tissue environment regulates neutrophil production and phenotypes, how neutrophil activity is controlled intracellularly and how neutrophils function in different disease contexts. Such approach will not only reveal important aspects of the fine-tuned regulatory mechanisms of neutrophil activation but also permit the generation of tailored intervention strategies.
News
Events
Seminar series on "Understanding and improving animal experiments"
Online seminar for TRR 332 members and participating institutions.
2-6 pm. (Zoom link will be sent one week before the seminar).
The certificates will be provided ONLY to participants who registered. Certificates will be sent to the given email address one week after the event.
2nd Diversity, Identity & Fate at Biomedical Frontiers
The BMC Diversity Initiative has invited three distinguished Munich-based scientists to present their current research in translational optoacoustics (Miguel Pleitez), lipid metabolism and metabolic diseases (Susanna Hofmann), and oncolytic virus-based cancer immunotherapeutics (Jennifer Altomonte). They will also share insights into the key experiences and challenges that have defined their careers in research. Meet-the-speaker sessions following the talks will offer opportunities for questions and open discussion.
More information here.
Hybrid event; in München and via Zoom, in the BMC Small lecture Hall (15:00 – 17:45).
flashlight talk A1
Invited lecture by Mikael Karlsnon (Karolinska Institute)
Neutrophil regulation of immunotherapy for cancer is regulated by Type II interferon
MPI Münster Lecture Hall